PRELIMINARY EVIDENCE FOR THE INVOLVEMENT OF THE PUTATIVE 5-HT4 RECEPTOR IN ZACOPRIDE-INDUCED AND COPPER SULFATE-INDUCED VOMITING IN THE FERRET

Previous studies of the mechanism of zacopride-induced emesis in ferrets have concluded that it is mediated predominantly by an antagonist effect on 5-HT3 receptors although the possibility of a contribution from an agonist effect at 5-HT4 receptors was not excluded. This study shows that zacopride (200-mu-g/kg p.o.)-induced emesis can bc blocked by a 'high dose' (1000-mu-g/kg) of ICS205930 but not by a low dose (100-mu-g/kg) or by 'high doses' (1000-mu-g/kg) of another more selective 5-HT3 receptor antagonist granisetron. As ICS205930, at high doses, is reported to be a 5-HT4 receptor antagonist it appears likely that activation of 5HT4-receptors contributes to emesis induced by zacopride. 'High' doses of ICS205930, but not granisetron or ondansetron, can also block the vagally mediated emesis induced by oral CuSO4 suggesting that 5-HT4 receptors involved in emesis are closely associated with abdominal vagal afferents.